Send to a Friend Share

Hemispherx (HEB) Shares Down 15% Today and Down 45% Over Last Two Weeks

November 3, 2009 4:04 PM EST
HEB Hot Sheet
Overall Analyst Rating:
    BUY (= Flat)
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are continuing lower today following yesterday's update on Ampligen and the resulting 8% drop in the stock. Today, Hemispherx has tumbled more than 15%.

Notably, over the last two weeks (since October 21), shares of Hemispherx have sunk by more than 45% from $1.80 to around $1.13 today. Unfortunately for the bulls, volume during this period has been, on average, pretty heavy.

You May Also Be Interested In


Related Categories

Insiders' Blog, Momentum Movers

Add Your Comment





Follow StreetInsider.com On Twitter